Studies related to Apolipoprotein B and Hesperidin

Effects Of Glucosyl Hesperidin On Serum Lipids In Hyperlipidemic Subjects: Preferential Reduction In Elevated Serum Triglyceride Level

Effect Decrease
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 40
Sex Male
Age Range 18-29, 30-44, 45-64
Body Types Overweight
Notes for this study:
In hyperlipidemic men given either 100mg or 500mg of G-Hesperidin, there appeared to be more responders to a reduction in triglycerides (45-55% of the sample at both doses) and less responders for total cholesterol, LDL, and HDL (less than 20% of the sample getting more than a 10% reduction, and whole group effects failing to be statistically significant). The overall reduction in triglycerides for the whole group was only significant for the higher dose, and only occurred in the persons with higher triglycerides at baseline, and a reduction in LDL atherogenicity was thought to occur due to a decrease in Apolipoprotein B.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.